Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HFN cell therapy (GABAergic)
- Development stage
- Preclinical
- Lead developer
- Skin2Neuron
- Modality
- Cell Therapies
- Administration
- Intrathecal
01
Overview
HFN cell therapy (GABAergic) is an autologous cell therapy candidate being developed by Skin2Neuron for the treatment of schizophrenia and other psychiatric disorders. The therapy utilizes the company's proprietary HFN (Hair Follicle-derived Neural) platform to generate neural precursor cells from a patient's own hair follicles. These precursors are then differentiated into GABAergic neurons, which are characterized by the expression of Glutamate decarboxylase 67 (GAD67). The primary therapeutic goal is to restore or supplement GABAergic inhibitory signaling in the brain, addressing the GABAergic dysfunction that is a hallmark of schizophrenia and related psychiatric conditions. The program is currently in the preclinical stage of development.
- Other names
- GABAergic HFN cell therapyHair follicle-derived GABAergic neural precursor cellsHFN GABAergic cells
Beyond the preview
Go deeper on HFN cell therapy (GABAergic).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HFN cell therapy (GABAergic).